Daria Hazuda, Ph.D., has over 30 years of experience in the discovery and development of antivirals, antibacterials, and vaccines. She obtained her Ph.D. from SUNY Stony Brook. After a postdoctoral fellowship at Smith Kline and French, she joined Merck and held positions of increasing responsibility managing cross-functional research resulting in multiple approved drugs and vaccines including the first-in-class HIV integrase inhibitor, which won the 2008 Prix Galien award. Dr. Hazuda retired from Merck as the Vice President of Infectious Disease and Vaccines and Chief Scientific Officer of the Cambridge Research site. Currently, she leads infectious disease and vaccines at Generate:Biomedicines.